收藏切换
Structurally novel HDAC inhibitors based on the trans-β-arylacryl tetrahydroisoquinoline scaffold: the design, synthesis, and anti-cancer activity
收藏切换
PDF
Xin GAO1, Wei-wei HAN1, Shi-yi TIAN1, Fang FANG1, 2, 3, *, Xiao-dong MA1, 2, 3, Hua-yi CHAI1, Jing-jing HAN1
Acta Pharmaceutica Sinica | 2023, 58(2) : 413 - 422
Less
收藏切换
Acta Pharmaceutica Sinica | 2023, 58(2): 413-422
Original Articles
Structurally novel HDAC inhibitors based on the trans-β-arylacryl tetrahydroisoquinoline scaffold: the design, synthesis, and anti-cancer activity
Full
Xin GAO1, Wei-wei HAN1, Shi-yi TIAN1, Fang FANG1, 2, 3, *, Xiao-dong MA1, 2, 3, Hua-yi CHAI1, Jing-jing HAN1
Affiliations
  • 1. College of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, China
  • 2. Department of Medicinal Chemistry, Anhui Academy of Chinese Medicine, Hefei 230012, China
  • 3. Anhui Province Key Laboratory of Research & Development of Chinese Medicine, Hefei 230012, China
Published: 2023-02-12 doi: 10.16438/j.0513-4870.2022-1083
Outline
收藏切换

In this study, a series of 18 histone deacetylases inhibitors (HDACis), derived from our in-house anti-cancer trans-β-arylacryl 1, 2, 3, 4-tetrahydroisoquinoline-based scaffold, were designed, synthesized, and antitumor evaluated. HDAC1 inhibitory activity assay showed that compounds 13d-13f and 13m-13o demonstrated attractive enzymatic activity with IC50 at single-digit nanomolar or subnanomolar level.In addition, 13o exerted superior anti-proliferative activity (A549, IC50 = 0.89 μmol·L-1; HCT116, IC50 = 0.49 μmol·L-1) to that of vorinostat (SAHA).Besides, 13e, with the most potent HDAC1 enzymatic activity (IC50 = 3.8 nmol·L-1), also displayed attractive cellular activity (A549, IC50 = 1.74 μmol·L-1; HCT116, IC50 = 2.43 μmol·L-1). The Western blot analysis illustrated that 13e treatment increased the acetylation of H3 and α-tubulin in a dose-dependent manner in A549 cells. In summary, 13e and 13o deserve further functional investigation.

HDAC inhibitor  /  tetrahydroisoquinoline  /  trans-β-arylacryl  /  anti-cancer
Xin GAO, Wei-wei HAN, Shi-yi TIAN, Fang FANG, Xiao-dong MA, Hua-yi CHAI, Jing-jing HAN. Structurally novel HDAC inhibitors based on the trans-β-arylacryl tetrahydroisoquinoline scaffold: the design, synthesis, and anti-cancer activity[J]. Acta Pharmaceutica Sinica, 2023 , 58 (2) : 413 -422 . DOI: 10.16438/j.0513-4870.2022-1083
Year 2023 volume 58 Issue 2
PDF
237
98
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2022-1083
  • Receive Date:2022-09-29
  • Online Date:2025-11-21
  • Published:2023-02-12
Article Data
Affiliations
History
  • Received:2022-09-29
  • Revised:2022-11-03
Funding
Affiliations
    1. College of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, China
    2. Department of Medicinal Chemistry, Anhui Academy of Chinese Medicine, Hefei 230012, China
    3. Anhui Province Key Laboratory of Research & Development of Chinese Medicine, Hefei 230012, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2022-1083
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT